These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 23782572)

  • 1. Long-term effects of recombinant human growth hormone therapy in children with Prader-Willi syndrome.
    Wolfgram PM; Carrel AL; Allen DB
    Curr Opin Pediatr; 2013 Aug; 25(4):509-14. PubMed ID: 23782572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome.
    Carrel AL; Myers SE; Whitman BY; Eickhoff J; Allen DB
    J Clin Endocrinol Metab; 2010 Mar; 95(3):1131-6. PubMed ID: 20061431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The behavioral impact of growth hormone treatment for children and adolescents with Prader-Willi syndrome: a 2-year, controlled study.
    Whitman BY; Myers S; Carrel A; Allen D
    Pediatrics; 2002 Feb; 109(2):E35. PubMed ID: 11826245
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial.
    Yang A; Choi JH; Sohn YB; Eom Y; Lee J; Yoo HW; Jin DK
    Orphanet J Rare Dis; 2019 Sep; 14(1):216. PubMed ID: 31511031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
    Myers SE; Carrel AL; Whitman BY; Allen DB
    J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sustained benefits of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome are dose-dependent.
    Carrel AL; Myers SE; Whitman BY; Allen DB
    J Pediatr Endocrinol Metab; 2001; 14(8):1097-105. PubMed ID: 11592566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth Hormone Treatment for Prader-Willi Syndrome.
    Tauber M; Diene G; Molinas C
    Pediatr Endocrinol Rev; 2018 Sep; 16(Suppl 1):91-99. PubMed ID: 30378786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early psychomotor development and growth hormone therapy in children with Prader-Willi syndrome: a review.
    Jin YY; Luo FH
    Eur J Pediatr; 2024 Mar; 183(3):1021-1036. PubMed ID: 37987848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study.
    Sode-Carlsen R; Farholt S; Rabben KF; Bollerslev J; Schreiner T; Jurik AG; Christiansen JS; Höybye C
    Endocrine; 2012 Apr; 41(2):191-9. PubMed ID: 22081257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Growth Hormone Treatment for Adults With Prader-Willi Syndrome: A Meta-Analysis.
    Rosenberg AGW; Passone CGB; Pellikaan K; Damiani D; van der Lely AJ; Polak M; Bernardo WM; de Graaff LCG
    J Clin Endocrinol Metab; 2021 Sep; 106(10):3068-3091. PubMed ID: 34105729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial.
    Mogul HR; Lee PD; Whitman BY; Zipf WB; Frey M; Myers S; Cahan M; Pinyerd B; Southren AL
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1238-45. PubMed ID: 18211968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to growth hormone treatment in Prader-Willi syndrome: auxological criteria versus genetic diagnosis.
    Scheermeyer E; Hughes I; Harris M; Ambler G; Crock P; Verge CF; Craig ME; Bergman P; Werther G; van Driel M; Davies PS; Choong CS
    J Paediatr Child Health; 2013 Dec; 49(12):1045-51. PubMed ID: 23781979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone improves body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome: A controlled study.
    Carrel AL; Myers SE; Whitman BY; Allen DB
    J Pediatr; 1999 Feb; 134(2):215-21. PubMed ID: 9931532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone therapy for Prader-Willi syndrome: a critical appraisal.
    Allen DB; Carrel AL
    J Pediatr Endocrinol Metab; 2004 Sep; 17 Suppl 4():1297-306. PubMed ID: 15506076
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term effects of growth hormone therapy on patients with Prader-Willi syndrome.
    Sipilä I; Sintonen H; Hietanen H; Apajasalo M; Alanne S; Viita AM; Leinonen E
    Acta Paediatr; 2010 Nov; 99(11):1712-8. PubMed ID: 20545932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone improves body composition and motor development in infants with Prader-Willi syndrome after six months.
    Whitman B; Carrel A; Bekx T; Weber C; Allen D; Myers S
    J Pediatr Endocrinol Metab; 2004 Apr; 17(4):591-600. PubMed ID: 15198290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone treatment for Prader-Willi syndrome: A review.
    Yang X
    Neuropeptides; 2020 Oct; 83():102084. PubMed ID: 32859387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone, gender and face shape in Prader-Willi syndrome.
    de Souza MA; McAllister C; Suttie M; Perrotta C; Mattina T; Faravelli F; Forzano F; Holland A; Hammond P
    Am J Med Genet A; 2013 Oct; 161A(10):2453-63. PubMed ID: 23918156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome.
    Deal CL; Tony M; Höybye C; Allen DB; Tauber M; Christiansen JS;
    J Clin Endocrinol Metab; 2013 Jun; 98(6):E1072-87. PubMed ID: 23543664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects on growth and metabolism of growth hormone treatment for 3 years in 36 children with Prader-Willi syndrome.
    Colmenares A; Pinto G; Taupin P; Giuseppe A; Odent T; Trivin C; Laborde K; Souberbielle JC; Polak M
    Horm Res Paediatr; 2011 Feb; 75(2):123-30. PubMed ID: 20847547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.